Cargando…

Drug resistance gene expression and chemotherapy sensitivity detection in Chinese women with different molecular subtypes of breast cancer

OBJECTIVE: The aim of the study was to identify specific chemosensitivity drugs for various molecular subtypes of breast tumors in Chinese women, by detecting the expression of drug resistance genes and by using the drug sensitivity test on different molecular subtypes of breast cancers. METHODS: Th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Jing, Zhang, Hailian, Lei, Ting, Liu, Juntian, Zhang, Shichao, Wu, Nan, Sun, Bo, Wang, Meng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Compuscript 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7721095/ https://www.ncbi.nlm.nih.gov/pubmed/33299650 http://dx.doi.org/10.20892/j.issn.2095-3941.2020.0157

Ejemplares similares

Evaluation of predictive and prognostic value of androgen receptor expression in breast cancer subtypes treated with neoadjuvant chemotherapy
por: Shi, Zhendong, et al.
Publicado: (2023)

Gene pathways associated with prognosis and chemotherapy sensitivity in different molecular subtypes of breast cancer
por: Pusztai, L
Publicado: (2011)

The mutation landscape of multiple cancer predisposition genes in Chinese familial/hereditary breast cancer families
por: Dong, Li, et al.
Publicado: (2022)

Association Study Confirmed Three Breast Cancer‐Specific Molecular Subtype‐Associated Susceptibility Loci in Chinese Han Women
por: Xu, Yihui, et al.
Publicado: (2017)

Heterogeneity and potential therapeutic insights for triple-negative breast cancer based on metabolic‐associated molecular subtypes and genomic mutations
por: Li, Lijuan, et al.
Publicado: (2023)

Patterns of distant metastasis in Chinese women according to breast cancer subtypes
por: Wu, San-Gang, et al.
Publicado: (2016)

Comparison of BSGI, MRI, mammography, and ultrasound for the diagnosis of breast lesions and their correlations with specific molecular subtypes in Chinese women
por: Liu, Hongbiao, et al.
Publicado: (2020)

Value of Breast Cancer Molecular Subtypes and Ki67 Expression for the Prediction of Efficacy and Prognosis of Neoadjuvant Chemotherapy in a Chinese Population
por: Wang, Jiayu, et al.
Publicado: (2016)

Evaluation of the pathological response and prognosis following neoadjuvant chemotherapy in molecular subtypes of breast cancer
por: Zhao, Yue, et al.
Publicado: (2015)

Interpretation of breast cancer screening guideline for Chinese women
por: Huang, Yubei, et al.
Publicado: (2019)

The value of FATS expression in predicting sensitivity to radiotherapy in breast cancer
por: Zhang, Jun, et al.
Publicado: (2017)

The disparities in prognostic prediction and annualized hazard function in different molecular subtypes between young Chinese and White American women with breast cancer
por: Zeng, Yuanyuan, et al.
Publicado: (2023)

Survival following radiotherapy in young women with localized early‐stage breast cancer according to molecular subtypes
por: Liu, Qi‐Qi, et al.
Publicado: (2019)

Clinicopathologic and molecular characteristics of 44 patients with pure secretory breast carcinoma
por: Li, Lijuan, et al.
Publicado: (2019)

Pathway-Based Drug Repositioning for Breast Cancer Molecular Subtypes
por: Mejía-Pedroza, Raúl A., et al.
Publicado: (2018)

Analysis of Tau Protein Expression in Predicting Pathological Complete Response to Neoadjuvant Chemotherapy in Different Molecular Subtypes of Breast Cancer
por: Lei, Chuqian, et al.
Publicado: (2020)

Distinct distribution and prognostic significance of molecular subtypes of breast cancer in Chinese women: a population-based cohort study
por: Su, Yinghao, et al.
Publicado: (2011)

Associations between body mass index and molecular subtypes as well as other clinical characteristics of breast cancer in Chinese women
por: Chen, Fei-Yu, et al.
Publicado: (2013)

Impact of Molecular Subtype Conversion of Breast Cancers after Neoadjuvant Chemotherapy on Clinical Outcome
por: Lim, Siew Kuan, et al.
Publicado: (2016)

Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection
por: Lehmann, Brian D., et al.
Publicado: (2016)

Ceramide expression in relation to breast cancer molecular subtypes in Saudi women
por: Almomen, Aliyah, et al.
Publicado: (2021)

Erratum: Analysis of Tau Protein Expression in Predicting Pathological Complete Response to Neoadjuvant Chemotherapy in Different Molecular Subtypes of Breast Cancer
por: Lei, Chuqian, et al.
Publicado: (2020)

Indoleamine-2,3-dioxygenase and Interleukin-6 associated with tumor response to neoadjuvant chemotherapy in breast cancer
por: Li, Fangxuan, et al.
Publicado: (2017)

Expression of the Androgen Receptor and its Correlation with Molecular Subtypes in 980 Chinese Breast Cancer Patients
por: Qi, Ji-ping, et al.
Publicado: (2011)

Development and validation of polygenic risk scores for prediction of breast cancer and breast cancer subtypes in Chinese women
por: Hou, Can, et al.
Publicado: (2022)

Cancer Hallmarks, Biomarkers and Breast Cancer Molecular Subtypes
por: Dai, Xiaofeng, et al.
Publicado: (2016)

The Relevance of Breast Cancer Subtypes in the Outcome of Neoadjuvant Chemotherapy
por: Straver, M. E., et al.
Publicado: (2010)

Prediction consistency and clinical presentations of breast cancer molecular subtypes for Han Chinese population
por: Huang, Chi-Cheng, et al.
Publicado: (2012)

Pattern of distant recurrence according to the molecular subtypes in Korean women with breast cancer
por: Park, Hyung Seok, et al.
Publicado: (2012)

Molecular subtypes of triple-negative breast cancer in women of different race and ethnicity
por: Ding, Yuan Chun, et al.
Publicado: (2019)

Reproductive risk factors associated with breast cancer in young women by molecular subtype
por: Ruddy, Kathryn J., et al.
Publicado: (2022)

Distinct molecular subtypes of uterine leiomyosarcoma respond differently to chemotherapy treatment
por: An, Yang, et al.
Publicado: (2017)

Metaplastic breast cancer: Treatment and prognosis by molecular subtype
por: Hu, Jin, et al.
Publicado: (2021)

An Aptamer-Based Probe for Molecular Subtyping of Breast Cancer
por: Liu, Mei, et al.
Publicado: (2018)

Clinical and epidemiologic factors associated with breast cancer and its subtypes among Northeast Chinese women
por: Ye, Dong‐Man, et al.
Publicado: (2019)

Impact of Immunohistochemistry-Based Molecular Subtype on Chemosensitivity and Survival in Patients with Breast Cancer Following Neoadjuvant Chemotherapy
por: Yoo, Changhoon, et al.
Publicado: (2012)

Influence of delayed initiation of adjuvant chemotherapy on breast cancer survival is subtype-dependent
por: Yu, Ke-Da, et al.
Publicado: (2016)

Prognosis of subtypes of the mucinous breast carcinoma in Chinese women: a population-based study of 32-year experience (1983-2014)
por: Pan, Bo, et al.
Publicado: (2016)

Distinct outcomes in patients with different molecular subtypes of inflammatory breast cancer
por: Zhou, Jingyu, et al.
Publicado: (2014)

Breast cancer subtyping by immunohistochemistry and histological grade outperforms breast cancer intrinsic subtypes in predicting neoadjuvant chemotherapy response
por: Lips, E. H., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_gtg7vok6c3h79vcvc5orh9hp29